Preventing major operative site infection after radical abdominal hysterectomy and pelvic lymphadenectomy.
Gynecol Oncol
; 35(1): 55-60, 1989 Oct.
Article
em En
| MEDLINE
| ID: mdl-2792903
ABSTRACT
Twenty-one women who underwent radical abdominal hysterectomy and pelvic lymphadenectomy were enrolled in a prospective, comparative, randomized, placebo-controlled clinical trial of antimicrobial prophylaxis. Preoperative endocervical flora was identified and was similar in pre- and postmenopausal private and clinic service women; 46% of the 119 preoperative isolates produced beta-lactamase enzyme. Women were given three doses of either placebo or cefoperazone plus sulbactam, an irreversible beta-lactamase enzyme inhibitor. Three women (27%) given placebo developed abdominal incision infections; one women given placebo also developed a pelvic infection. None given antibiotic developed operative site infection, but one women developed a drain site infection. A major operative site infection rate of 27% observed with placebo is high enough to warrant prophylaxis. Although antimicrobial prophylaxis at radical hysterectomy and pelvic lymphadenectomy eradicted operative site infection in our patient populations, a literature review indicates that individual determination of a requirement for prophylaxis is necessary.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Pré-Medicação
/
Infecção da Ferida Cirúrgica
/
Sulbactam
/
Cefoperazona
/
Histerectomia
/
Excisão de Linfonodo
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Observational_studies
Limite:
Adult
/
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
1989
Tipo de documento:
Article